Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms
Journal of Psychoactive Drugs – January 27, 2022
Source: OpenAlex
Summary
A compelling case documented a single individual experiencing reduced obsessive-compulsive disorder (OCD) symptoms after psilocybin consumption. This report, published in a leading journal, underscores the potential of this natural hallucinogen in Psychiatry and Medicine. While such findings from Complementary and Alternative Medicine Studies are intriguing for Psychology, the broader field of Psychedelics and Drug Studies increasingly emphasizes rigorous clinical trials. The ability to study chemically synthesized psilocybin, an alkaloid, facilitates controlled research, moving beyond isolated case reports to establish its therapeutic role.
Abstract
The Journal of Psychoactive Drugs published a case study reporting reduction of obsessive-compulsive disorder (OCD) symptoms after consumption of psilocybincontaining mushrooms (Lugo-Radillo & Cortes-Lopez, 2021).We subsequently received a letter suggesting that psychedelic research has progressed beyond case studies, and recommending that journals focus on publication of clinical trials rather than case reports.